Pharming Group N.V. (PHAR)

Nasdaq: PHAR · Pharmaceutical Preparations · Leiden, NL · filing with the SEC since 2020

Grade6.9

◀ Past 7.1● Present 7.0▶ Future 6.4

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Report filed	Apr 2, 2026	Apr 3, 2025	Apr 4, 2024	Apr 5, 2023	Apr 6, 2022	Apr 7, 2021	·
Revenue	376,134	297,200	245,316	205,622	198,871	212,174	189,389
Cost of revenue	45,500	35,399	25,212	17,562	21,142	23,539	23,928
Gross profit	330,634	261,801	220,104	188,060	177,729	188,635	165,461
Research and development	100,367	83,147	68,914	52,531	70,369	38,519	31,786
Sales and marketing	130,995	118,802	124,049	85,803	59,445	51,604	44,724
General and administrative	79,958	70,650	55,877	46,016	36,974	24,085	21,192
Total operating expenses	311,320	272,599	248,840	184,350	166,788	114,208	97,702
Operating income	25,842	-8,621	-5,387	18,233	13,561	76,256	68,246
Finance costs	196	56	134	105	94	74	0
Net finance income (costs)	-13,618	1,889	-6,336	-2,163	8,823	-32,524	-16,199
Share of profit of equity-method investments	623	-1,760	-289	-1,083	694	362	257
Income before income taxes	12,847	-8,492	-12,012	14,987	23,078	44,094	52,304
Income tax expense	10,310	3,349	-1,464	1,313	7,082	6,348	11,747
Net income	2,538	-11,841	-10,548	13,674	15,996	37,746	40,557
Net income to non-controlling interests	-313	0	0	·	·	·	·
Net income to shareholders	2,851	-11,841	-10,548	·	·	·	·
Earnings per share, basic	0.004	-0.018	-0.016	0.021	0.025	0.058	0.065
Earnings per share, diluted	0.004	-0.018	-0.016	0.019	0.023	0.055	0.06
Weighted average shares, basic	688,773,370	671,347,279	657,020,521	648,676,119	642,007,692	636,268,929	626,315,013
Weighted average shares, diluted	746,866,045	785,412,134	725,463,948	707,141,263	701,151,525	682,737,280	673,519,995

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:RevenueFromContractsWithCustomers

Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales

Gross profit revenue less the cost of what it soldifrs-full:GrossProfit

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersifrs-full:SalesAndMarketingExpense

General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherifrs-full:OperatingExpenseExcludingCostOfSales

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:FinanceCosts

Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost

Share of profit of equity-method investments its share of companies it partly ownsifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton PHAR · research, not advice